Heterozygous RAP1B gain-of-<wbr></wbr>function variants alter integrin-mediated platelet activation and lymphocyte trafficking, with mosaicism resulting in isolated thrombocytopenia and immunodeficiency while germline mutations involve multiple tissues. This evidence concerns the gene RAP1B and immune system disorder.